| | | | | | Product | Package Size | EFP | CP | SB | DC | Composition | Registr. Holder | Category | | |
|---|
| What is an ATC-Code? | ATC-Overview |
|
| L | | IP | CI | | UROCIT | 100 Tablet(s) | 41.33 | 61.35 | 10 % | | Tablets: Kalii Citras 1080 mg | Recordati AG | B / SL | FB | G |
|
| | | IP | CI | | Urispas | 30 Tablet(s) | 6.93 | 16.75 | 10 % | | Coated tablets: Flavoxati Hydrochloridum 200 mg | Recordati AG | B / SL | FB | G |
| | | IP | CI | | Urispas | 100 Tablet(s) | 19.63 | 37.75 | 10 % | | Coated tablets: Flavoxati Hydrochloridum 200 mg | Recordati AG | B / SL | FB | G |
|
| | | IP | CI | | Emselex 7.5 mg - T | 14 Tablet(s) | 10.20 | 27.50 | 10 % | | Delayed release tablets: Darifenacinum 7.5 mg | CPS Cito Pharma
Services GmbH | B / SL | FB | G |
| | | IP | CI | | Emselex 7.5 mg - T | 56 Tablet(s) | 40.77 | 60.75 | 10 % | | Delayed release tablets: Darifenacinum 7.5 mg | CPS Cito Pharma
Services GmbH | B / SL | FB | G |
| | | IP | CI | | Emselex 15 mg - T | 14 Tablet(s) | 10.20 | 27.50 | 10 % | | Delayed release tablets: Darifenacinum 15 mg | CPS Cito Pharma
Services GmbH | B / SL | FB | G |
| | | IP | CI | | Emselex 15 mg - T | 56 Tablet(s) | 40.77 | 60.75 | 10 % | | Delayed release tablets: Darifenacinum 15 mg | CPS Cito Pharma
Services GmbH | B / SL | FB | G |
|
| | SIP | IP | CI | | Toviaz, Retardtabletten 4 mg | 14 Tablet(s) | 9.92 | 27.15 | 10 % | | Fesoterodini Fumaras 4 mg | Pfizer AG | B / SL / SO | FB | G |
| | SIP | IP | CI | | Toviaz, Retardtabletten 4 mg | 84 Tablet(s) | 57.92 | 79.10 | 10 % | | Fesoterodini Fumaras 4 mg | Pfizer AG | B / SL / SO | FB | G |
| | SIP | IP | CI | | Toviaz, Retardtabletten 8 mg - T | 14 Tablet(s) | 10.39 | 27.65 | 10 % | | Fesoterodini Fumaras 8 mg | Pfizer AG | B / SL / SO | FB | G |
| | SIP | IP | CI | | Toviaz, Retardtabletten 8 mg - T | 84 Tablet(s) | 60.91 | 82.30 | 10 % | | Fesoterodini Fumaras 8 mg | Pfizer AG | B / SL / SO | FB | G |
| | | IP | CI | | Fesoterodin Spirig HC
retard 4 mg | 14 | 9.02 | 26.25 | 10 % | | Delayed release tablets: Fesoterodini Fumaras 4 mg | Spirig HealthCare AG | B / SL / SG | FB | G |
| | | IP | CI | | Fesoterodin Spirig HC
retard 4 mg | 84 | 52.66 | 73.70 | 10 % | | Delayed release tablets: Fesoterodini Fumaras 4 mg | Spirig HealthCare AG | B / SL / SG | FB | G |
| | | IP | CI | | Fesoterodin Spirig HC
retard 8 mg | 14 | 9.45 | 26.70 | 10 % | | Delayed release tablets: Fesoterodini Fumaras 8 mg | Spirig HealthCare AG | B / SL / SG | FB | G |
| | | IP | CI | | Fesoterodin Spirig HC
retard 8 mg | 84 | 55.38 | 76.65 | 10 % | | Delayed release tablets: Fesoterodini Fumaras 8 mg | Spirig HealthCare AG | B / SL / SG | FB | G |
| | | IP | CI | | Fesoterodin Zentiva 4 mg | 14 | 9.02 | 26.25 | 10 % | | Delayed release tablets: Fesoterodini Fumaras 4 mg | Helvepharm AG | B / SL / SG | FB | G |
| | | IP | CI | | Fesoterodin Zentiva 4 mg | 84 | 52.66 | 73.70 | 10 % | | Delayed release tablets: Fesoterodini Fumaras 4 mg | Helvepharm AG | ● B / SL / SG | FB | G |
| | | IP | CI | | Fesoterodin Zentiva 8 mg | 14 | 9.45 | 26.70 | 10 % | | Delayed release tablets: Fesoterodini Fumaras 8 mg | Helvepharm AG | B / SL / SG | FB | G |
| | | IP | CI | | Fesoterodin Zentiva 8 mg | 84 | 55.38 | 76.65 | 10 % | | Delayed release tablets: Fesoterodini Fumaras 8 mg | Helvepharm AG | ● B / SL / SG | FB | G |
| | | IP | CI | | Fesoterodin-Mepha 4 mg | 14 | 9.02 | 26.25 | 10 % | | Delayed release tablets: Fesoterodini Fumaras 4 mg | Mepha Pharma AG | B / SL / SG | FB | G |
| | | IP | CI | | Fesoterodin-Mepha 4 mg | 84 | 52.66 | 73.70 | 10 % | | Delayed release tablets: Fesoterodini Fumaras 4 mg | Mepha Pharma AG | B / SL / SG | FB | G |
| | | IP | CI | | Fesoterodin-Mepha 8 mg | 14 | 9.45 | 26.70 | 10 % | | Delayed release tablets: Fesoterodini Fumaras 8 mg | Mepha Pharma AG | B / SL / SG | FB | G |
| | | IP | CI | | Fesoterodin-Mepha 8 mg | 84 | 55.38 | 76.65 | 10 % | | Delayed release tablets: Fesoterodini Fumaras 8 mg | Mepha Pharma AG | B / SL / SG | FB | G |
|
| | | IP | CI | PP | Betmiga 25 mg | 30 Tablet(s) | 34.22 | 53.65 | 10 % | | Delayed release tablets: Mirabegronum 25 mg | Astellas Pharma AG | B / SL | FB | G |
| | | IP | CI | PP | Betmiga 25 mg | 90 Tablet(s) | 100.72 | 125.95 | 10 % | | Delayed release tablets: Mirabegronum 25 mg | Astellas Pharma AG | B / SL | FB | G |
| | | IP | CI | PP | Betmiga 50 mg | 30 Tablet(s) | 34.22 | 53.65 | 10 % | | Delayed release tablets: Mirabegronum 50 mg | Astellas Pharma AG | B / SL | FB | G |
| | | IP | CI | PP | Betmiga 50 mg | 90 Tablet(s) | 100.72 | 125.95 | 10 % | | Delayed release tablets: Mirabegronum 50 mg | Astellas Pharma AG | B / SL | FB | G |
|
| L | | IP | CI | | Caverject 10 ug | Durchstechflasche(n) | 9.65 | 26.90 | 10 % | | Injection preparation: Alprostadilum 10 µg | Pfizer AG | A / SL | FB | G |
| L | | IP | CI | | Caverject DC 10 | 2 syringe(s) | 16.39 | 34.25 | 10 % | | Injection preparation: Alprostadilum 10 µg | Pfizer AG | ● A / SL | FB | G |
| L | | IP | CI | | Caverject DC 20 | 2 syringe(s) | 27.78 | 46.65 | 10 % | | Pulver und Lösungsmittel zur Herstellung einer Injektionslösung in einer Fertigspritze: Alprostadilum 20 µg | Pfizer AG | ● A / SL | FB | G |
| | | IP | CI | | Caverject 20 ug | Durchstechflasche(n) | | | k.A. | | Injection preparation: Alprostadilum 20 µg | Pfizer AG | A | FB | G |
|
| | | IP | CI | | Spedra 50 mg | 4 Tablet(s) | | | k.A. | | Tablets: Avanafilum 50 mg | Curatis AG | B | FB | G |
| | | IP | CI | | Spedra 50 mg | 12 Tablet(s) | | | k.A. | | Tablets: Avanafilum 50 mg | Curatis AG | B | FB | G |
| | | IP | CI | | Spedra 100 mg | 4 Tablet(s) | | | k.A. | | Tablets: Avanafilum 100 mg | Curatis AG | B | FB | G |
| | | IP | CI | | Spedra 100 mg | 12 Tablet(s) | | | k.A. | | Tablets: Avanafilum 100 mg | Curatis AG | B | FB | G |
| | | IP | CI | | Spedra 200 mg | 4 Tablet(s) | | | k.A. | | Tablets: Avanafilum 200 mg | Curatis AG | B | FB | G |
| | | IP | CI | | Spedra 200 mg | 12 Tablet(s) | | | k.A. | | Tablets: Avanafilum 200 mg | Curatis AG | B | FB | G |
| | | IP | CI | | Spedra 50 mg | 8 Tablet(s) | | | k.A. | | Tablets: Avanafilum 50 mg | Curatis AG | B | FB | G |
| | | IP | CI | | Spedra 100 mg | 2 Tablet(s) | | | k.A. | | Tablets: Avanafilum 100 mg | Curatis AG | B | FB | G |
| | | IP | CI | | Spedra 100 mg | 8 Tablet(s) | | | k.A. | | Tablets: Avanafilum 100 mg | Curatis AG | B | FB | G |
| | | IP | CI | | Spedra 200 mg | 8 Tablet(s) | | | k.A. | | Tablets: Avanafilum 200 mg | Curatis AG | B | FB | G |
|
| | | IP | CI | Ph | Cystinol | 40 Tablet(s) | | | k.A. | | | Medinova AG | D | FB | G |
| | | | CI | Ph | Sidroga Blasen- und
Nierentee | 20 x 1.3 g | | | k.A. | | | Uriach Switzerland AG | D | FB | G |
| | | | CI | PhCM | Amavita Nieren- und
Blasendragées | 40 | | | k.A. | | Coated tablets: 3 Active Agents | Amavita Health Care AG | D | FB | G |
| | | | CI | PhCM | Coop Vitality Nieren- und
Blasendragées | 40 | | | k.A. | | Coated tablets: 3 Active Agents | Coop Vitality Health
Care GmbH | D | FB | G |
| | | | CI | Ph | Nieren- und Blasendragées S | 40 Dragée(s) | | | k.A. | | Coated tablets: 3 Active Agents | Hänseler AG | D | FB | G |
| | | | CI | Ph | Nieren- und Blasendragées S | 60 Dragée(s) | | | k.A. | | Coated tablets: 3 Active Agents | Hänseler AG | D | FB | G |
| | | | CI | CM | SUN STORE Nieren- und
Blasendragées | 40 | | | k.A. | | Coated tablets: 3 Active Agents | Sun Store Health Care AG | D | FB | G |
| | | IP | CI | | Arkocaps Busserole
nouvelle formule | 45 | | | k.A. | | Capsules: Uvae ursi Folii Pulvis 350 mg | Arko Diffusion AG | D | FB | G |
| | | | CI | Ph | Arkocaps Orthosiphon 325 mg | 45 Capsule(s) | | | k.A. | | Capsules: Orthosiphonis Pulvis 325 mg | Arko Diffusion AG | D | FB | G |
| | | | CI | Ph | Arkocaps Orthosiphon 325 mg | 150 Capsule(s) | | | k.A. | | Capsules: Orthosiphonis Pulvis 325 mg | Arko Diffusion AG | D | FB | G |
| | | IP | CI | Ph | Granufink femina | 60 Capsule(s) | | | k.A. | | Capsules: 3 Active Agents | Perrigo Schweiz AG | D | FB | G |
| | | IP | CI | Ph | Granufink femina | 120 Capsule(s) | | | k.A. | | Capsules: 3 Active Agents | Perrigo Schweiz AG | D | FB | G |
| | | IP | CI | | Uro-Vaxom | 3 x 10 Capsule(s) | | | k.A. | | Capsules: Escherichiae coli Lysati Filtratum 6 mg | OM Pharma SA | B | FB | G |
| | | IP | CI | | Uro-Vaxom | 9 x 10 Capsule(s) | | | k.A. | | Capsules: Escherichiae coli Lysati Filtratum 6 mg | OM Pharma SA | B | FB | G |
| | | | CI | Ph | Sidroga Birkenblätter | 20 x 1.5 g | | | k.A. | | Arzneitee: Betulae Folium (Betula Pendula roth und / oder Betula Pubescens ehrh., Folium) 1.5 g | Uriach Switzerland AG | D | FB | G |
| | | | CI | Ph | Sidroga
Brennnesselblätter | 20 1 Teebeutel à 1.5 g | | | k.A. | | Arzneitee: Urticae Folium (Urtica Dioica l. Und/oder Urtica Urens l., Folium) 1.5 g | Uriach Switzerland AG | D | FB | G |
| | | | CI | Ph | Sidroga
Bärentraubenblätter | 20 1 Teebeutel à 2 g | | | k.A. | | Arzneitee: Uvae ursi Folium (Arctostaphylos Uva-Ursi (L.) Spreng) 2 g | Uriach Switzerland AG | D | FB | G |
| | | | CI | Ph | Sidroga Harntee | 20 1 Teebeutel à 1.5 g | | | k.A. | | Arzneitee: 4 Active Agents | Uriach Switzerland AG | D | FB | G |
| | | | CI | Ph | Sidroga Schachtelhalm | 20 1 Teebeutel à 2 g | | | k.A. | | Arzneitee: Equiseti Herba (Equisetum Arvense l., Herba) 2 g | Uriach Switzerland AG | D | FB | G |
| | | IP | CI | | Canephron | 30 | | | k.A. | | überzogene Tabletten: 3 Active Agents | Biomed AG | D | FB | G |
| | | | | PhCM | Floramed Blasentee | 20 1 Sachet(s) à 1.5 g | | | k.A. | | Chopped herbs: 5 Active Agents | Morga AG | E | FB | G |
| | | | | Ph | Morga Blasentee | 20 1 Sachet(s) à 1.5 g | | | k.A. | | Chopped herbs: 5 Active Agents | Morga AG | E | FB | G |
| | | | | | Angomed | 75 | | | k.A. | | Coated tablets: 2 Active Agents | Zeller Medical AG | D | FB | G |
| | | | CI | Ph | Nieren- und Blasendragées S | 20 Dragée(s) | | | k.A. | | Coated tablets: 3 Active Agents | Hänseler AG | D | FB | G |
| | | | | PhCM | Swidro Nieren- und
Blasendragées | 20 Dragée(s) | | | k.A. | | Coated tablets: 3 Active Agents | Hänseler AG | D | FB | G |
| | | | | PhCM | Swidro Nieren- und
Blasendragées | 40 | | | k.A. | | Coated tablets: 3 Active Agents | Hänseler AG | D | FB | G |
| | | IP | CI | Ph | Granufink femina | 30 Capsule(s) | | | k.A. | | Capsules: 3 Active Agents | Perrigo Schweiz AG | D | FB | G |
| | | | | Ph | Klostergarten Blasentee
Benedictus | 20 x 1.5 g | | | k.A. | | Arzneitee: 7 Active Agents | Migros-
Genossenschafts-Bund | E | FB | G |
|
| | | IP | CI | | PRILIGY | 3 Tablet(s) | | | k.A. | | Coated tablets: Dapoxetinum 30 mg | Curatis AG | B | FB | G |
| | | IP | CI | | PRILIGY | 6 Tablet(s) | | | k.A. | | Coated tablets: Dapoxetinum 30 mg | Curatis AG | B | FB | G |
|
| | | | CI | H | Sanukehl Coli D7 | 10 1 ampoule(s) à 1 ml | | | k.A. | | | ebi-pharm ag | B | FB | G |
| | | | CI | H | Sanukehl Prot D7 | 10 1 ampoule(s) à 1 ml | | | k.A. | | | ebi-pharm ag | B | FB | G |
| | | | CI | H | Sanukehl Prot D7 | 50 1 ampoule(s) à 1 ml | | | k.A. | | | ebi-pharm ag | B | FB | G |
| | | | CI | H | Blasosan | 10 g | | 19.50 | k.A. | | Globules: 6 Active Agents | Tentan AG | D | FB | G |
| | | | CI | | Omida
Blasenschwächechügeli für
Kinder | 10 g | | | k.A. | | Globules: 4 Active Agents | Schwabe Pharma AG | D | FB | G |
| | | | CI | H | Similasan Nieren-Blasen-
Beschwerden | 15 g | | | k.A. | | Globules: 3 Active Agents | Similasan AG | D | FB | G |
| | | | CI | H | Dr. Reckeweg R 27
Renocalcin | 50 ml | | | k.A. | | Drops: 4 Active Agents | Laboratoire Jacques
Reboh et fils SA | B | FB | G |
| | | | CI | H | Sanukehl Pseu D6 | 10 ml | | | k.A. | | Drops: Pseudomonas Aeruginosa Extractum (Lyophil., Steril.) Aquos D6 Dilutio | ebi-pharm ag | B | FB | G |
| | | | CI | H | Akutur | 50 ml | | | k.A. | | Tropfen zum Einnehmen: 4 Active Agents | ebi-pharm ag | D | FB | G |
| | | | CI | H | Blasosan | 50 ml | | 19.50 | k.A. | | Tropfen zum Einnehmen: 6 Active Agents | Tentan AG | D | FB | G |
| | | | CI | | Omida Nieren- und
Blasentropfen | 60 ml | | | k.A. | | Tropfen zum Einnehmen: 4 Active Agents | Schwabe Pharma AG | D | FB | G |
| | | | CI | H | Sanukehl Coli D6 | 10 ml | | | k.A. | | Tropfen zum Einnehmen und Einreiben: Escherichia coli Extractum Cellulae (Lyophil., Steril.) D6 (Hab 5A) 1 ml | ebi-pharm ag | B | FB | G |
| | | | CI | H | Sanukehl Prot D6 | 10 ml | | | k.A. | | Tropfen zum Einnehmen und Einreiben: Proteus Vulgaris Extractum Cellulae (Lyophil., Steril.) D6 (Hab 5A) 1 ml | ebi-pharm ag | B | FB | G |
| | | | CI | H | Dr. Reckeweg R 64
Nephralbin | 50 ml | | | k.A. | | gouttes buvables: 4 Active Agents | Laboratoire Jacques
Reboh et fils SA | D | FB | G |
| | | | CI | H | Dr. Reckeweg R 18
Cystophylin | 50 ml | | | k.A. | | gouttes buvables: 5 Active Agents | Laboratoire Jacques
Reboh et fils SA | D | FB | G |
| | | | CI | H | Dr. Reckeweg R 74
Nocturnin | 50 ml | | | k.A. | | gouttes buvables: 5 Active Agents | Laboratoire Jacques
Reboh et fils SA | D | FB | G |
| | | | CI | H | Sanukehl Coli D7 | ampoule(s) à 1 ml | | | k.A. | | | ebi-pharm ag | B | FB | G |
| | | | CI | H | Sanukehl Coli D7 | 50 1 ampoule(s) à 1 ml | | | k.A. | | | ebi-pharm ag | B | FB | G |
| | | | CI | H | Sanukehl Prot D7 | ampoule(s) à 1 ml | | | k.A. | | | ebi-pharm ag | B | FB | G |
| | | | CI | H | Regenaplex Nr. 86a | 15 ml | | | k.A. | | Drops: 7 Active Agents | Regena AG | B | FB | G |
| | | | CI | H | Regenaplex Nr. 88b | 15 ml | | | k.A. | | Tropfen zum Einnehmen: 8 Active Agents | Regena AG | D | FB | G |
| | | | CI | H | Regenaplex Nr. 50b | 15 ml | | | k.A. | | Tropfen zum Einnehmen: 8 Active Agents | Regena AG | D | FB | G |
| | | | CI | H | Regenaplex Nr. 51c | 15 ml | | | k.A. | | Tropfen zum Einnehmen: 8 Active Agents | Regena AG | D | FB | G |
| | | | | | Cystorénol | 15 ml | | | k.A. | | Drops: 6 Active Agents | Laboratoire Dr. E.
Homberger SA | C | FB | G |
| | | | | | Cystorénol | 30 ml | | | k.A. | | Drops: 6 Active Agents | Laboratoire Dr. E.
Homberger SA | C | FB | G |
| | | | | | Cystorénol | 60 ml | | | k.A. | | Drops: 6 Active Agents | Laboratoire Dr. E.
Homberger SA | C | FB | G |
| | | | | | Enuresyl | 15 ml | | 6.20 | k.A. | | Drops: 6 Active Agents | Laboratoire Dr. E.
Homberger SA | C | FB | G |
| | | | | | Enuresyl | 30 ml | | 10.30 | k.A. | | Drops: 6 Active Agents | Laboratoire Dr. E.
Homberger SA | C | FB | G |
| | | | | | Enuresyl | 60 ml | | 18.60 | k.A. | | Drops: 6 Active Agents | Laboratoire Dr. E.
Homberger SA | C | FB | G |
